Scott Dodson presented at Canaccord last week and a number of private funds are impressed and either getting in or increasing. He also presented in NZ last week at a big biotech conference - I am told by an impartial investor in Biotech stocks that the AXP presentation was the best of the conference.
SP rise most likely represents the confidence shared by the market that FDA approval will succeed and the US arms of production (Costa Rica) and sales / distribution is ready to roll out quickly.
Tyremen
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.684M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 29583410 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 59394450 | 39 |
View Market Depth
| Last trade - 16.13pm 20/06/2025 (20 minute delay) ? |
| AXP (ASX) Chart |
Day chart unavailable